Jim Jordan

We look forward to your scheduling this hearing promptly.

We would like a minority hearing day with those witnesses that we have asked to come.

I would just point out to my friend from Virginia, obviously different--different circumstance.

Yes, SOAR Act. Private schools, public schools, Opportunity Scholarship Program, right?

We cannot ignore the elephant in the room, ladies and gentlemen.

The District is simply not yet self-sustainable.

I hope we can have a frank discussion about the future of the District of Columbia.

I'm going to be here till the day I die defending the men and women of the Border Patrol and ICE.

We're a Nation of laws, we're a Nation of sovereignty.

It's not going to happen.

I just want to get--because your testimony is at the broader issue, and this is critically important.

Our Nation's heroes in ICE and Border Patrol are under attack. Their families are being attacked and bullied in public, in churches, and at schools.

Thousands of Angel Moms and Angel Dads have been born out of sanctuary policies, but I don't see the urgency that we have on things that we want to attack the administration on.

Criminal cartels are making millions of dollars a year because of congressional inaction, but I see no hearings on this.

I don't see the same sense of urgency when existing policies put our citizens in danger, puts this country's security in danger, or result in an unsecure border, which results in not just a humanitarian crisis, but a national security…

We're not doing our job to send clear signals and to make sure that the resources are there.

We are a Nation of laws, we're a Nation of sovereignty.

As a Member of Congress, as an American, as a Christian, we should be compassionate and do the right thing.

We want that innovation. We want people to take risk, come up with great idea, innovative things and do it.

Some on the other side of the aisle, though, feel that these high drug prices represent a failure of markets, a failure of capitalism.

We have all these lobbyists running around this town but no high-priced lobbyist will ever be the mom on a mission.

CREATES addresses a tactic the company that makes Revlimid, Celgene, uses to deny generic companies access to samples of Revlimid.

Laws and regulations that the government has put in place have led to the abuse of the patent system.

These challenges are tough. They require us to roll up our sleeves and do the tough work together.

Some on the other side of the aisle... feel that these high drug prices represent a failure of markets, a failure of capitalism.